Analysis of the correlation between non-alcoholic fatty liver disease and bone metabolism indicators in healthy middle-aged men.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  European Review for Medical and Pharmacological Sciences

• Publication date

  2018-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.26355/eurrev_201803_14493PMID 29565507
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Melatonin promotes osteoblast differentiation of bone marrow mesenchymal stem cells in aged rats.

  2017cited by this paper
• Thyrotropin serum levels are differentially associated with biochemical markers of bone turnover and stiffness in women and men: results from the SHIP cohorts

  2016cited by this paper
• Role of adiponectin in mediating the association of osteocalcin with insulin resistance and type 2 diabetes: a cross sectional study in pre- and post-menopausal women

  2014cited by this paper
• Osteocalcin levels are inversely associated with Hba1c and BMI in adult subjects with long-standing type 1 diabetes

  2014cited by this paper
• Osteocalcin and vitamin D status are inversely associated with homeostatic model assessment of insulin resistance in Canadian Aboriginal and white women: the First Nations Bone Health Study.

  2013cited by this paper
• Relationship between Serum Osteocalcin Levels and Non-Alcoholic Fatty Liver Disease in Adult Males, South China

  2013cited by this paper
• Inverse relationship between serum osteocalcin levels and visceral fat area in Chinese men.

  2013cited by this paper
• Relationship between serum osteocalcin levels and non‐alcoholic fatty liver disease in Chinese men

  2013cited by this paper
• Determinants of undercarboxylated and carboxylated osteocalcin concentrations in type 1 diabetes

  2012cited by this paper
• Relation of osteocalcin with insulin resistance and histopathological changes of non alcoholic fatty liver disease.

  2011cited by this paper
• Serum concentrations of osteocalcin, procollagen type 1 N‐terminal propeptide and beta‐CrossLaps in obese subjects with varying degrees of glucose tolerance

  2011cited by this paper
• Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults

  2011cited by this paper
• Guidelines for management of nonalcoholic fatty liver disease: an updated and revised edition.

  2010cited by this paper
• Risk of fractures and bone abnormalities in postmenopausal women with type 2 diabetes mellitus.

  2010cited by this paper
• Plasma Osteocalcin Is Inversely Related to Fat Mass and Plasma Glucose in Elderly Swedish Men

  2009cited by this paper
• Serum osteocalcin concentrations in relation to glucose and lipid metabolism in Chinese individuals.

  2009cited by this paper
• Comparative Effects of Teriparatide and Strontium Ranelate on Bone Biopsies and Biochemical Markers of Bone Turnover in Postmenopausal Women With Osteoporosis

  2009cited by this paper
• Prevalence of fatty liver disease and its risk factors in the population of South China.

  2007cited by this paper
• Endocrine regulation of energy metabolism by the skeleton.

  2007cited by this paper
• A New Monoclonal Antibody ELISA for Detection and Characterization of C-telopeptide Fragments of Type I Collagen in Urine

  2001cited by this paper
• Osteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone.

  1989cited by this paper

• Association of metabolic dysfunction-associated steatotic liver disease with bone health in adults: a systematic review and meta-analysis of observational studies

  2026cites this paper
• Serum Osteopontin and Procollagen Type 1 N-Terminal Propeptide Concentrations: Links to Liver Function, Muscle Mass, and Bone Mineral Density in MASLD and Hypertension

  2025cites this paper
• The clinical potential of undercarboxylated osteocalcin in metabolic and neurodegenerative diseases: From biomarker to therapeutic target

  2025cites this paper
• In vitro osteoclast differentiation enhanced by hepatocyte supernatants from high-fat diet mice

  2024cites this paper
• Diagnostic Performance of Biomarker-Based Scores as Predictors of Metabolic Dysfunction-Associated Fatty Liver Disease Risk in Healthy Children

  2023cites this paper
• Bone Turnover Markers in Adults with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis

  2023cites this paper
• Low levels of osteocalcin, but not CTX or P1NP, associated with nonalcoholic hepatic steatosis and steatohepatitis.

  2022cites this paper
• Stratification by Non-invasive Biomarkers of Non-alcoholic Fatty Liver Disease in Children

  2022cites this paper
• Loss of the incretin effect in type 2 diabetes: a systematic review and meta-analysis.

  2022cites this paper
• Association between non-alcoholic fatty liver disease and bone turnover markers in southwest China

  2022cites this paper
• Decreased Serum Osteocalcin is an Independent Risk Factor for Metabolic Dysfunction-Associated Fatty Liver Disease in Type 2 Diabetes

  2022cites this paper
• Osteocalcin and Non‐Alcoholic Fatty Liver Disease: Lessons From Two Population‐Based Cohorts and Animal Models

  2020cites this paper
• Osteocalcin and osteoprotegerin levels and their relationship with adipokines and proinflammatory cytokines in children with nonalcoholic fatty liver disease.

  2020cites this paper
• Key molecular pathways in the progression of non-alcoholic steatohepatitis.

  2019cites this paper
• Cardiolipin inhibitor ameliorates the non-alcoholic steatohepatitis through suppressing NLRP3 inflammasome activation.

  2019cites this paper
• Analysis of the correlation between non-alcoholic fatty liver disease and bone metabolism indicators in healthy middle-aged men.

  2018cites this paper